机构ID,机构名称,公告日期,开始日期,截止日期,报告年度,合并类型,报表来源,销售商品、提供劳务收到的现金（元）,收到的税费返还,收到其他与经营活动有关的现金,经营活动现金流入小计,购买商品、接受劳务支付的现金,支付给职工以及为职工支付的现金,支付的各项税费,支付其他与经营活动有关的现金,经营活动现金流出小计,经营活动产生的现金流量净额,收回投资收到的现金,取得投资收益收到的现金,处置固定资产、无形资产和其他长期资产收回的现金净额,处置子公司及其他营业单位收到的现金净额,收到其他与投资活动有关的现金,投资活动现金流入小计,购建固定资产、无形资产和其他长期资产支付的现金,投资支付的现金,质押贷款净增加额,取得子公司及其他营业单位支付的现金净额,支付其他与投资活动有关的现金,投资活动现金流出小计,投资活动产生的现金流量净额,吸收投资收到的现金,取得借款收到的现金,发行债券收到的现金,收到其他与筹资活动有关的现金,筹资活动现金流入小计,偿还债务支付的现金,分配股利、利润或偿付利息支付的现金,支付其他与筹资活动有关的现金,筹资活动现金流出小计,筹资活动产生的现金流量净额,四、汇率变动对现金的影响,四(2)、其他原因对现金的影响,五、现金及现金等价物净增加额,期初现金及现金等价物余额,期末现金及现金等价物余额,附注：,1、将净利润调节为经营活动现金流量：,净利润,加：资产减值准备,固定资产折旧、油气资产折耗、生产性生物资产折旧,无形资产摊销,长期待摊费用摊销,处置固定资产、无形资产和其他长期资产的损失,固定资产报废损失,公允价值变动损失,财务费用,投资损失,递延所得税资产减少,递延所得税负债增加,存货的减少,经营性应收项目的减少,经营性应付项目的增加,其他,经营活动产生的现金流量净额2,2、不涉及现金收支的重大投资和筹资活动：,债务转为资本,一年内到期的可转换公司债券,融资租入固定资产,3、现金及现金等价物净变动情况：,现金的期末余额,减：现金的期初余额,加：现金等价物的期末余额,减：现金等价物的期初余额,加：其他原因对现金的影响2,现金及现金等价物净增加额2,客户存款和同业存放款项净增加额,向中央银行借款净增加额,向其他金融机构拆入资金净增加额,收到原保险合同保费取得的现金,收到再保险业务现金净额,保户储金及投资款净增加额,处置以公允价值计量且其变动计入当期损益的金融资产净增加额,收取利息、手续费及佣金的现金,拆入资金净增加额,回购业务资金净增加额,客户贷款及垫款净增加额,存放中央银行和同业款项净增加额,支付原保险合同赔付款项的现金,支付利息、手续费及佣金的现金,支付保单红利的现金,其中：子公司吸收少数股东投资收到的现金,其中：子公司支付给少数股东的股利、利润,投资性房地产的折旧及摊销
603658,安图生物,2016-08-11,2016-01-01,2016-06-30,2016-06-30,合并本期,招募说明书,489720522.95,0.0,14944995.26,504665518.21,84824270.67,107862638.69,82721360.48,55271386.9,330679656.74,173985861.47,,0.0,200,,,200.0,83120515.88,6300000.0,,,,89420515.88,-89420315.88,0.0,9794005.0,,0.0,9794005.0,8455343.87,2707465.9,300000.0,11462809.77,-1668804.77,21636.94,,82918377.76,196232728.86,279151106.62,,,147742450.73,865996.08,32043296.09,436129.05,1127161.36,357107.85,,,-144040.85,828257.49,-2288093.89,2968280.69,-8691820.04,-23067152.16,25027368.47,-3219079.4,173985861.47,,,,,,279151106.62,196232728.86,,,,82918377.76,,,,,,,,,,,,,,,,,,
603658,安图生物,2016-10-26,2016-01-01,2016-09-30,2016-09-30,合并本期,定期报告,778963242.93,,19712167.27,798675410.2,162476558.07,152063005.14,132278187.76,87701944.22,534519695.19,264155715.01,,,30200,,0.0,30200.0,118914256.31,6300000.0,,,0.0,125214256.31,-125184056.31,584640880.0,9794005.0,,0.0,594434885.0,105499291.62,3764422.75,2519000.0,111782714.37,482652170.63,24597.2,,621648426.53,196232728.86,817881155.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
603658,安图生物,2017-03-03,2016-01-01,2016-12-31,2016-12-31,合并本期,定期报告,1087475694.07,5177.68,28714993.26,1116195865.01,199435695.99,195638446.57,175879592.19,129425781.04,700379515.79,415816349.22,,,49200,,648310253.97,648359453.97,237415763.14,6300000.0,,,1438600000.0,1682315763.14,-1033956309.17,584640880.0,9794005.0,,,594434885.0,105499291.62,3764422.75,8109000.0,117372714.37,477062170.63,1056595.39,,-140021193.93,196232728.86,56211534.93,,,349758059.57,2953838.18,72547047.61,1028339.58,2488712.73,739974.22,0.0,0.0,-554832.7,267326.74,-4820460.46,7375501.18,-8907951.93,-115725193.22,115207050.76,-6541063.04,415816349.22,,0.0,0.0,0.0,,56211534.93,196232728.86,0.0,0.0,,-140021193.93,,,,,,,,,,,,,,,,,,
603658,安图生物,2017-04-25,2017-01-01,2017-03-31,2017-03-31,合并本期,定期报告,320350840.24,48089.03,5017348.01,325416277.28,86489031.33,91834405.93,37136979.23,21426035.57,236886452.06,88529825.22,,,10000,,909365989.19,909375989.19,203930718.74,,,,722900000.0,926830718.74,-17454729.55,,,,,,,,,,,-324049.4,,70751046.27,56211534.93,126962581.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
603658,安图生物,2017-08-03,2017-01-01,2017-06-30,2017-06-30,合并本期,定期报告,681397841.76,48089.03,10140350.54,691586281.33,191688802.08,138154098.49,83236413.0,59772512.37,472851825.94,218734455.39,,,10000,,2339659305.88,2339669305.88,286968495.46,,,90401482.95,1891500000.0,2268869978.41,70799327.47,,,,,,,273000000.0,,273000000.0,-273000000.0,-601445.35,,15932337.51,56211534.93,72143872.44,,,191431554.29,751845.21,44874229.61,9353714.14,1582351.84,69000.84,0.0,0.0,869563.35,-12968965.72,-6112342.51,6009185.14,36120660.92,-3535160.82,-46429678.8,-3281502.1,218734455.39,,0.0,0.0,0.0,,72143872.44,56211534.93,0.0,0.0,,15932337.51,,,,,,,,,,,,,,,,,,
